潜在的物理化合物用于开发尿路感染治疗方法
Ajit Kumar Bishoyi1, Anjali Lakra1, Chinmayee Priyadarsani Mandhata1
1Central Research Laboratory, Institute of Medical Sciences & Sum Hospital, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, Odisha, 751003, India.
抗生素耐药性构成重大威胁,耐药细菌导致常见的感染,如尿路感染 (UTI). 本综述探讨了天然产品作为这些具有挑战性的细菌感染的潜在治疗方法.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 细菌的抗生素耐药性是一个日益增长的全球性挑战,复杂化了常见感染的治疗.
- 鼻腔感染越来越普遍,通常是由多药耐药细菌引起的.
- 尿路感染 (UTI) 是一个主要的公共卫生问题,抗生素耐药性率不断上升.
研究的目的:
- 提供有关尿路感染相关疾病及其治疗挑战的全面更新.
- 突出全球尿路感染的发病率和抗生素耐药性的日益增长.
- 探索天然产品,特别是植物化合物的潜力,以对抗耐药细菌感染.
主要方法:
- 文献综述和综合关于抗生素耐药性和尿路感染的最新研究.
- 对尿路感染发病率和细菌耐药性模式的全球统计数据的分析.
- 检查抗菌应用的天然产品研究的进展.
主要成果:
- 抗生素耐药性是治疗细菌感染的关键问题,包括尿路感染.
- 自然产品,特别是植物化合物,显示出作为新型抗菌剂的前景.
- 需要新的治疗策略来对抗多药耐药细菌.
结论:
- 尿路感染很常见,由于抗生素耐药性,治疗越来越困难.
- 自然产品为开发新的抗菌疗法提供了一个有希望的途径.
- 物理化合物是未来药物开发新型抗菌候选物的潜在来源.
更多相关视频
07:34Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
Published on: April 16, 2019
09:50Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization
Published on: October 18, 2019
相关概念视频
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug Elimination by Renal Route: Tubular Secretion
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Elimination by Renal Route: Tubular Reabsorption
